Details of the Drug Reposition

General Information of This Drug (ID: DMXTOCE)

• Drug Name: XmAb13676 (DMXTOCE)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
B-cell lymphoma	DISIH1YQ	2A86	Phase 1	[1]
Non-hodgkin lymphoma	DISS2Y8A	2B33.5	Phase 1	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)